Rosacea: Pathogenesis and Therapeutic Correlates

(A) Proposed cathelicidins pathway believed to be implicated in the pathogenesis of rosacea. Production of LL-37 leads to several physiological effects including angiogenesis, vasodilation, inflammation, and matrix degradation. (i) High densities of Demodex folliculorum upregulates the expression of TLR2 in sebocytes. Enhanced TLR2 activity leads to increased KLK5 activity and production of LL-37. (ii) CagA+ and VacA+ Helicobacter pylori strains stimulate mast cell activation and subsequent increase in histamines and prostaglandins, promoting inflammation. (iii) Through MMP2 upregulation and TLR2 signalling, ROS promote matrix degeneration and increase LL-37 production. (iv) UV promotes expression of CAMP in keratinocytes via vitamin D-dependent and ER stress-induced pathways. CAMP can then be cleaved into the bioactive LL-37 fragments. (B) Proposed inflammasome pathway believed to be implicated in the pathogenesis of rosacea. Inflammasome activation results in several physiological effects including chemotaxis of neutrophils, angiogenesis, and inflammation. The cathelicidins and inflammasome pathways are intricately linked. TLR2, toll-like receptor 2; KLK5, kallikrein-5; CagA+, cytotoxin-associated gene A positive; VacA+, vacuolating cytotoxin A positive; MMP2, matrix metalloprotease 2; ROS, reactive oxygen species; UV, ultraviolet; CAMP, cathelicidin antimicrobial peptide; ER, endoplasmic reticulum.
Rosacea: Pathogenesis and Therapeutic Correlates

Publication

Rosacea: Pathogenesis and Therapeutic Correlates. (2024) Ryan S. Q. Geng, et al. J Cutan Med Surg. 2024 Mar-Apr;28(2):178-189. Figure: F2.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID

Chemical mentions

Word Match MeSH Name ChEBI

Disease mentions

Word Match MeSH Name DOID